Drugs and Health

Drugs and Viral Hepatitis

Viral hepatitis data repository

This repository provides data for a range of indicators related to viral hepatitis and people who inject drugs. Data is sourced from a range of publicly available international datasets, including the UNODC World Drug Report, UNAIDS, the Global Health Observatory, the Global Burden of Disease, the Polaris Observatory and academic modelling studies.

The repository provides global and national estimates for each indicator, as well as estimates for the nine Global State of Harm Reduction regions.

Indicators

  • LOW DEAD SPACE SYRINGES: ANALYSIS AND BENEFITS FOR PEOPLE WHO INJECT DRUGS

  • Population size estimates for people who inject drugs

  • Prevalence of injecting drug use (%) in the general population, aged 15-64

  • Prevalence of active hepatitis B virus infection (HBsAg) among people who inject drugs and the general population

  • Percentage of total population with active hepatitis B infection who are current people who inject drugs

  • Prevalence of viraemic hepatitis C infection among people who inject drugs and the general population

  • Percentage of total population with active hepatitis C infection who are current people who inject drugs

  • Prevalence of HIV among people who inject drugs and the general population

  • Prevalence of HIV and hepatitis C among people who inject drugs and the general population

  • Percentage of deaths and DALYs due to hepatitis B attributable to drug use

  • Percentage of deaths and DALYs due to hepatitis C attributable to drug use

  • Percentage of new hepatitis C infections attributable to injecting drug use

  • Ratio of hepatitis C viraemia prevalence in people who inject drugs : general population

    • Don't miss our events
    and publications

    Subscribe to our newsletter